Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-rRNA processing defect in Diamond-Blackfan anemia.

Archive ouverte

Gazda, Hanna T | Preti, Milena | Sheen, Mee Rie | O'Donohue, Marie-Françoise | Vlachos, Adrianna | Davies, Stella M | Kattamis, Antonis | Doherty, Leana | Landowski, Michael | Buros, Christopher | Ghazvinian, Roxanne | Sieff, Colin A | Newburger, Peter E | Niewiadomska, Edyta | Matysiak, Michal | Glader, Bertil | Atsidaftos, Eva | Lipton, Jeffrey M | Gleizes, Pierre-Emmanuel | Beggs, Alan H

Edité par CCSD ; Wiley -

International audience. Diamond-Blackfan anemia (DBA) is an inherited form of pure red cell aplasia that usually presents in infancy or early childhood and is associated with congenital malformations in ∼30-50% of patients. DBA has been associated with mutations in nine ribosomal protein (RP) genes in about 53% of patients. We completed a large scale screen of 79 RP genes by sequencing 16 RP genes (RPL3, RPL7, RPL8, RPL10, RPL14, RPL17, RPL19, RPL23A, RPL26, RPL27, RPL35, RPL36A, RPL39, RPS4X, RPS4Y1, and RPS21) in 96 DBA probands. We identified a de novo two-nucleotide deletion in RPL26 in one proband associated with multiple severe physical abnormalities. This mutation gives rise to a remarkable ribosome biogenesis defect that affects maturation of both the small and the large subunits. We also found a deletion in RPL19 and missense mutations in RPL3 and RPL23A, which may be variants of unknown significance. Together with RPL5, RPL11, and RPS7, RPL26 is the fourth ribosomal protein regulating p53 activity that is linked to DBA.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion